News

FDA asks Novavax for commitment on post-approval studies for COVID vaccine
Novavax on Wednesday said the U.S. Food and Drug Administration has asked the company to commit to produce more data on its ...
Novavax stock jumps on positive FDA discussions
Investing.com -- Novavax (NASDAQ: NVAX) shares surged 13% following the biotechnology company’s optimism about its Biologics License Application (BLA) with the U.S. Food and Drug Administration (FDA).
Devdiscourse20m
Key Developments in US Domestic Affairs
The current US domestic news highlights involve President Trump's stance on Federal Reserve Chair Jerome Powell, cybercrime ...
Novavax Inc. stock outperforms competitors on strong trading day
Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...
Endpoints News1h
FDA asks No­vavax for post-mar­ket­ing da­ta of its Covid vac­cine, de­lay­ing ap­proval
The FDA has asked Novavax to commit to producing post-marketing data of its Covid vaccine, the clearest example yet that the bar is higher for advancing new vaccines under HHS Secretary Robert F.
Zacks Investment Research on MSN22h
Verastem Oncology to Report Q1 Earnings: What's in the Cards?
We expect investors to focus on Verastem Oncology’s VSTM progress with the development of its pipeline candidates being ...